Romney Scrambling to Alter Stock Portfolio After Questionable Dealings Revealed

Republican presidential candidate Mitt Romney is scrambling to change his investments after a Herald report that he holds stock in companies that perform embryonic stem cell research –a practice that clashes with his conversion to an anti-abortion presidential candidate. As he faced questions on the campaign trail yesterday, Romney denied specific knowledge of the stem cell investments, but said he expects his money will be pulled from firms whose work conflicts with his beliefs.

“The trustee of the blind trust has said publicly that he will endeavor to make my investments conform with my positions, and I am confident that he will,” Romney said during a stop in Georgia.

The Herald reported yesterday that Romney, considered a top-tier candidate for the GOP presidential nomination, owns stock in Novo Nordisk and Millipore Corp., which use human embryos to conduct disease research.

Romney, who holds assets worth between $190 million and $250 million, also invests in casino operators, an oil company that does business with Iran and a firm with cash linked to the genocidal Sudanese government.

( Link )